Oncogenic stress sensitizes murine cancers to hypomorphic suppression of ATR
Published 2011 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Oncogenic stress sensitizes murine cancers to hypomorphic suppression of ATR
Authors
Keywords
-
Journal
JOURNAL OF CLINICAL INVESTIGATION
Volume 122, Issue 1, Pages 241-252
Publisher
American Society for Clinical Investigation
Online
2011-12-03
DOI
10.1172/jci58928
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Discovery of Potent and Selective Inhibitors of Ataxia Telangiectasia Mutated and Rad3 Related (ATR) Protein Kinase as Potential Anticancer Agents
- (2011) Jean-Damien Charrier et al. JOURNAL OF MEDICINAL CHEMISTRY
- Targeting ATR and Chk1 kinases for cancer treatment: A new model for new (and old) drugs
- (2011) Luis I. Toledo et al. Molecular Oncology
- Selective killing of ATM- or p53-deficient cancer cells through inhibition of ATR
- (2011) Philip M Reaper et al. Nature Chemical Biology
- A cell-based screen identifies ATR inhibitors with synthetic lethal properties for cancer-associated mutations
- (2011) Luis I Toledo et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- Efficacy of CHK inhibitors as single agents in MYC-driven lymphoma cells
- (2011) P T Ferrao et al. ONCOGENE
- Chk1 is essential for chemical carcinogen-induced mouse skin tumorigenesis
- (2011) L M Tho et al. ONCOGENE
- Protection from UV-induced skin carcinogenesis by genetic inhibition of the ataxia telangiectasia and Rad3-related (ATR) kinase
- (2011) M. Kawasumi et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Combining ATR Suppression with Oncogenic Ras Synergistically Increases Genomic Instability, Causing Synthetic Lethality or Tumorigenesis in a Dosage-Dependent Manner
- (2010) O. Gilad et al. CANCER RESEARCH
- Removing all obstacles: A critical role for p53 in promoting tissue renewal
- (2010) David W. Schoppy et al. CELL CYCLE
- Selective activation of p53-mediated tumour suppression in high-grade tumours
- (2010) Melissa R. Junttila et al. NATURE
- Stage-specific sensitivity to p53 restoration during lung cancer progression
- (2010) David M. Feldser et al. NATURE
- Phosphorylation of MLL by ATR is required for execution of mammalian S-phase checkpoint
- (2010) Han Liu et al. NATURE
- Death by releasing the breaks: CHK1 inhibitors as cancer therapeutics
- (2010) Cynthia X. Ma et al. TRENDS IN MOLECULAR MEDICINE
- Mouse models of human AML accurately predict chemotherapy response
- (2009) J. Zuber et al. GENES & DEVELOPMENT
- Tim–Tipin dysfunction creates an indispensible reliance on the ATR–Chk1 pathway for continued DNA synthesis
- (2009) Kevin D. Smith et al. JOURNAL OF CELL BIOLOGY
- Tissue regenerative delays and synthetic lethality in adult mice after combined deletion of Atr and Trp53
- (2009) Yaroslava Ruzankina et al. NATURE GENETICS
- A mouse model of ATR-Seckel shows embryonic replicative stress and accelerated aging
- (2009) Matilde Murga et al. NATURE GENETICS
- Chk1 deficiency in the mouse small intestine results in p53-independent crypt death and subsequent intestinal compensation
- (2009) K R Greenow et al. ONCOGENE
- Dual inactivation of Hus1 and p53 in the mouse mammary gland results in accumulation of damaged cells and impaired tissue regeneration
- (2009) Stephanie A. Yazinski et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- ATR and H2AX Cooperate in Maintaining Genome Stability under Replication Stress
- (2008) Rebecca A. Chanoux et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Apoptotic signaling by c-MYC
- (2008) B Hoffman et al. ONCOGENE
- An Oncogene-Induced DNA Damage Model for Cancer Development
- (2008) T. D. Halazonetis et al. SCIENCE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search